Contraception News and Research

Latest Contraception News and Research

Teen birth rates in US still highest among developed countries

Teen birth rates in the United States are still 33 percent higher than in New Zealand, the developed country with the next highest incidence — even though U.S. rates have fallen from a high of 62 per 1,000 teens in the early 1990s to a record low of 41 in 2005, a new study finds.

29 Sep 2010

Bayer’s new oral contraceptive receives FDA approval

Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved a new oral contraceptive, Beyaz (drospirenone / ethinyl estradiol / levomefolate calcium tablets and levomefolate calcium tablets).

28 Sep 2010

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

"The best way to help the millions of hungry people in countries that receive food aid get rid of their corrupt and incompetent rulers - and to ensure that their children will never go hungry in future — is to starve them now. That will turn them into raging, unstoppable anti-government regime changers," writes Nation Media Group Executive Editor Charles Onyango-Obbo in an East African opinion piece.

28 Sep 2010

Hologic receives FDA voting for 3-D digital mammography system

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced that the Radiological Devices Panel (Panel) of the U.S. Food and Drug Administration (FDA) today unanimously voted that Hologic's Pre-Market Approval (PMA) demonstrated both the effectiveness and safety of the Company's Selenia Dimensions three-dimensional (3-D) digital mammography tomosynthesis system, "Selenia Dimensions 3-D."

From Hologic, Inc. 27 Sep 2010

FDA approves Beyaz tablets to increase folate level in women

The U.S. Food and Drug Administration today approved Beyaz tablets, an estrogen/progestin combined oral contraceptive that also contains a folate (levomefolate calcium 0.451 mg).

27 Sep 2010

Today's Opinions: Coloradans' insurance concerns, contraception and New York's Medicaid burden

For years, Coloradans have lived with uncertainty about their health insurance: lifetime caps, recisions, coverage for life-saving screenings. New provisions that begin Thursday, the six-month anniversary of the signing of the Affordable Care Act, address some of the biggest concerns consumers had about the failing health system (Dede de Percin, 9/22).

23 Sep 2010

Health overhaul details trigger uncertainty, debate

The Orlando Sentinel: "It's one of the most overlooked pieces of health-care overhaul, but a plan to help companies pay health-care costs for early retirees has proved popular in Florida, where 69 companies and government agencies have applied for federal help.

22 Sep 2010

HHS urged not to cover contraception or sterilization in health plans

The Department of Health and Human Services (HHS) should not require coverage of contraception or sterilization in group and individual health plans as part of "preventive" services for women, said representatives of the United States Conference of Catholic Bishops (USCCB) as HHS continued its deliberations on a final list of required preventive services under the Patient Protection and Affordable Care Act (PPACA).

21 Sep 2010

Actress Claire Danes joins thumbprint mosaic in Save the Children's EVERY ONE campaign

Emmy award winning actress Claire Danes will join millions of people who've added their thumbprints to an innovative and unique global petition at Grand Central Terminal, lead by global humanitarian organisation Save the Children.

20 Sep 2010

HRA Pharma, Watson enter licensing agreement for ulipristal acetate emergency contraceptive commercialization

HRA Pharma, a privately-held, European pharmaceutical company that develops healthcare solutions in reproductive health and endocrinology and makes them available worldwide, and Watson Pharmaceuticals, Inc. announced today that they have entered into a licensing agreement for the commercialization of HRA Pharma's next generation emergency contraceptive ulipristal acetate in Canada.

18 Sep 2010

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences, Inc. today announced Phase II clinical trial results showing that its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat and Truvada (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection maintained a high rate of virologic suppression through 48 weeks, exhibiting antiretroviral activity comparable to that of Atripla(efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

14 Sep 2010

FDA approves Abreu BTT 700 System for temperature monitoring

Brain Tunnelgenix Technologies Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance to market its Abreu BTT 700 System for continuous temperature monitoring.

10 Sep 2010

Ovatech completes Phase 2 study of Ovaprene non-hormonal, intravaginal contraceptive ring

Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.

2 Sep 2010

Clinical interventions useful in reducing reproductive coercion, unintended pregnancy: Study

Specifically asking young women during visits to family planning clinics whether their partners had attempted to force them to become pregnant - a type of intimate-partner violence called reproductive coercion - dramatically reduced the likelihood that the women would continue to experience such pressures, according to a new pilot study led by researchers at the UC Davis School of Medicine.

31 Aug 2010

Canadian minister travels to Mali, Mozambique to start rolling out Canada's G8 Muskoka Initiative

The Canadian government started rolling out its maternal health program in Africa as Minister of International Co-operation Bev Oda embarked on a seven-day visit to Mali and Mozambique, the Globe and Mail reports (York, 8/27).

31 Aug 2010

Also in Global Health News: GM mosquitoes; Iodine deficiency in Nepal; South African health workers strike; Novartis to build vaccine plant in Brazil; Population control in Niger

Malaysia is still "considering releasing" up to 3,000 mosquitoes that are genetically modified to "combat dengue fever, in a landmark field trial that has come in for criticism from environmentalists," Agence France-Presse reports. The insects are modified "so that their offspring quickly die," which researchers hope will cull the population and lessen the risk of dengue.

30 Aug 2010

First international technical conference for maternal health development

From August 30 to September 1, more than 600 maternal health experts will gather in Delhi, India, for the Global Maternal Health Conference 2010, the first international technical conference devoted exclusively to maternal health.

30 Aug 2010

Wis. pushes to expand Medicaid funding for contraceptives, Minnesota encourages 'medical homes,' Md. settles nursing home payment case

"Wisconsin is pushing to expand a controversial program that uses federal Medicaid funds to provide free birth-control pills, vasectomies and other forms of contraception to low-income people, an effort made possible by the federal health-care overhaul. It and 26 other states already provide free contraception and other reproductive-health services through a Medicaid pilot project to lower-earning women who otherwise wouldn't qualify."

19 Aug 2010

First Edition: August 18, 2010

In today's headlines, the National Association of Insurance Commissioners takes action on key recommendations related to health reform implementation.

18 Aug 2010

FDA considers dropping Avastin approval, approves five-day emergency contraception pill

The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.

17 Aug 2010

Contraception News and Research

Latest Contraception News and Research

Teen birth rates in US still highest among developed countries

Bayer’s new oral contraceptive receives FDA approval

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

Hologic receives FDA voting for 3-D digital mammography system

FDA approves Beyaz tablets to increase folate level in women

Today's Opinions: Coloradans' insurance concerns, contraception and New York's Medicaid burden

Health overhaul details trigger uncertainty, debate

HHS urged not to cover contraception or sterilization in health plans

Actress Claire Danes joins thumbprint mosaic in Save the Children's EVERY ONE campaign

HRA Pharma, Watson enter licensing agreement for ulipristal acetate emergency contraceptive commercialization

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

FDA approves Abreu BTT 700 System for temperature monitoring

Ovatech completes Phase 2 study of Ovaprene non-hormonal, intravaginal contraceptive ring

Clinical interventions useful in reducing reproductive coercion, unintended pregnancy: Study

Canadian minister travels to Mali, Mozambique to start rolling out Canada's G8 Muskoka Initiative

Also in Global Health News: GM mosquitoes; Iodine deficiency in Nepal; South African health workers strike; Novartis to build vaccine plant in Brazil; Population control in Niger

First international technical conference for maternal health development

Wis. pushes to expand Medicaid funding for contraceptives, Minnesota encourages 'medical homes,' Md. settles nursing home payment case

First Edition: August 18, 2010

FDA considers dropping Avastin approval, approves five-day emergency contraception pill

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Contraception News and Research

Latest Contraception News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in